Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma.

In patients with del(17p), there was a tendency toward a reduction in PFS, but this did not reach statistical significance (median PFS, 15.5 vs. 27.0 months, P = 0.0677) (Fig. 3 d).

also in 111,027 other papers